Profit Taking or Bear Market? Good day everyone, Our extended coverage of Vuzix last week worked out well. We alerted the company on Monday at $3.79/s...
FDA Approves Detectnet (copper Cu 64 dotatate injection) Positron Emission Tomography (PET) Agent
Article Link: FDA Approves Detectnet (copper Cu 64 dotatate injection) Positron Emission Tomography (PET) Agent Houston, TX and St. Louis...
FDA Approves Gavreto (pralsetinib) for the Treatment of Adults With Metastatic RET Fusion-Positive Non-Small Cell Lung Cancer
Article Link: FDA Approves Gavreto (pralsetinib) for the Treatment of Adults With Metastatic RET Fusion-Positive Non-Small Cell Lung Cancer ...
FDA Approves Additional Doses of Trulicity (dulaglutide) for the Treatment of Type 2 Diabetes
Article Link: FDA Approves Additional Doses of Trulicity (dulaglutide) for the Treatment of Type 2 Diabetes INDIANAPOLIS, Sept. 3, 2020 /...
FDA Approves Onureg (azacitidine tablets) as Continued Treatment for Adults in First Remission with Acute Myeloid Leukemia
Article Link: FDA Approves Onureg (azacitidine tablets) as Continued Treatment for Adults in First Remission with Acute Myeloid Leukemia ...
Revenues and Product Development are on Fire
Potential Value Indicated in Vuzix (VUZI) Shares Revenues and product development are on fire Good day everyone, We are continuing coverage of Vuzix C...
FDA Approves Xaracoll (bupivacaine hydrochloride) Implant for Acute Postsurgical Pain Relief Following Open Inguinal Hernia Repair
Article Link: FDA Approves Xaracoll (bupivacaine hydrochloride) Implant for Acute Postsurgical Pain Relief Following Open Inguinal Hernia Repair ...
FDA Approves Sogroya (somapacitan-beco) a Once-Weekly Treatment for Adult Growth Hormone Deficiency
Article Link: FDA Approves Sogroya (somapacitan-beco) a Once-Weekly Treatment for Adult Growth Hormone Deficiency Plainsboro, NJ, Aug 28,...
FDA Approves Winlevi (clascoterone) Cream for the Treatment of Acne
Article Link: FDA Approves Winlevi (clascoterone) Cream for the Treatment of Acne Lainate, Italy – August 27, 2020 – Cassiopea SpA (SIX: ...
FDA Approves Cystadrops (cysteamine) Ophthalmic Solution for the Ocular Manifestations of Cystinosis
Article Link: FDA Approves Cystadrops (cysteamine) Ophthalmic Solution for the Ocular Manifestations of Cystinosis LEBANON, N.J., Aug. 25...